The University of Minnesota's vaunted twins study had as good a shot as any to sort out the murky health effects of recreational marijuana.
By factoring out differences in genetics, upbringing and age, the study offered a purer comparison of twins who smoked marijuana vs. siblings who didn't. After comparing 364 sets of identical twins, the U researchers found in 2021 that the marijuana users had lower grades and were less likely to attend college and earn higher incomes.
But the study didn't find the cognitive declines and mental health problems others have ascribed to marijuana. Even twins lead different lives, so it's also possible other influences were at work, said Jonathan Schaefer, a lead author and researcher at the U's Institute of Child Development.
"By virtue of comparing twins, we can get a much more accurate estimate of the true effect of the drug," he said. "But it is still an estimate, and it's not necessarily wholly attributable to the drug."
Those uncertainties reflect Minnesota's paradox as its leaders debate whether to join 18 states in legalizing recreational marijuana. Few studies let marijuana off the hook, and yet its harms seem unclear or modest compared to tobacco or alcohol — making it hard to stand in the way of the people who want to smoke it, the industry that wants to sell it, and the politicians who want to spend its tax revenues.
Dr. Charles Reznikoff, an addiction medicine expert with Hennepin Healthcare, said persistent marijuana use has hurt some patients' health, jobs and families.
However, marijuana doesn't present the same lethal risk as opioids or alcohol, he said: "Cannabis use disorder, marijuana addiction, it's less destructive than other forms of addiction, and I think that's why it gets downplayed."
Research has focused on marijuana use from adolescence through young adulthood, because it could hamper brain development that continues through age 25.